The efficacy of luliconazole against Fusarium complex
محل انتشار: بیستمین کنگره بین المللی میکروب شناسی ایران
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 404
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
MEDISM20_188
تاریخ نمایه سازی: 26 بهمن 1398
چکیده مقاله:
Introduction and Objectives: Fusarium species are widespread saprophytic fungi that originally considered as phytopathogen, however during the last decades were shifted to humans and animals’ diseases. Fusarium solani is responsible for the majority cases of fusariosis, and usually causes severe infections with high mortality rates among predisposed patients. Fusarium species are inherently resistant to the most available antifungals in vitro with considerable high minimum inhibitory concentration (MIC). Luliconazole is a new antifungal that was originally used for the treatment of dermatophytosis. However, some study has shown that it has excellent efficacy against Aspergillus, and Candida species. The present study was aimed to the evaluation of luliconazole activity against some clinical and environmental isolates of Fusarium. Furthermore, this efficacy was compared to other systemic antifungals including; caspofungin, posaconazole, fluconazole, itraconazole, amphotericin B and voriconazole.Materials and Methods: In our study 48 isolates of Fusarium including 2 clinical isolates and 46 environmental isolates were tested against several antifungals. All species were identified using morphology features and PCR sequencing. Antifungal susceptibility was performed according to CLSI M38 A2 guideline against Fusarium species with luliconazole, caspofungin, posaconazole, fluconazole, itraconazole, amphotericin B and voriconazole. Results: Our results showed that luliconazole has very low MICGM value 1 to 0.0645 μg/ml in comparison with 2.78 μg/ml for posaconazole, 2.14 μg/ml for terbinafine, 0.54 μg/ml for itraconazole, 10.7 μg/ml for amphotericin B, 1.18 μg/ml for voriconazole and 1.39 for caspofungin. Also, the highest resistance to antifungal drugs were observed in amphotericin B (85.1%). Conclusion: Overall, our finding indicates that luliconazole has a great activity against environmental and clinical Fusarium species complex. As well as this drug has a potency to use for fusariosis.
کلیدواژه ها:
نویسندگان
Maral Gharaghani
Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Sahar Hivary
Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Simin Taghipour
Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Ali Zarei Mahmoudabadi
Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran